Retina Tablet 250 mg (Dovesil Calcium Hydrate)

Adult dose

Adults: Administer the following doses of calcium dobesilate hydrate orally. 1. Vascular damage and retinopathy: 500~1000mg daily 2. Venous disease: Administer 750mg daily for 1~3 weeks, followed by 500mg daily. Take after meals with plenty of fluids. Adjust the dose as appropriate according to age and symptoms.

This medication should not be used in patients with allergies to specific components. Additionally, this drug contains lactose, so it should not be administered to patients with genetically determined galactose intolerance, lactase deficiency, or glucose-galactose malabsorption. Caution is necessary in patients with impaired kidney function, as this drug is excreted through the kidneys; dosage adjustments may be needed for renal failure patients. Administer with caution in patients with impaired liver function; liver function tests should be reassessed if there is an increase in liver enzymes. This drug contains sodium metabisulfite, which may cause allergic reactions or asthma attacks, so individuals sensitive to sulfites should take care. While taking this medication, symptoms such as headache, abdominal pain, nausea, diarrhea, vomiting, joint pain, and muscle pain may occur. Rarely, blood-related abnormalities or severe allergic reactions may occur, so if symptoms such as fever, skin rash, or difficulty in breathing arise, notify a doctor immediately. If there are symptoms of infection, consult a doctor promptly and check status with blood tests if necessary. The influence of this medication on driving and operating machinery is unclear, so caution is advised. The use of this medication during pregnancy is limited and should be avoided when possible. This medication can be excreted in small amounts in breast milk, so it is recommended to stop breastfeeding or discontinue treatment. Safety for pediatric patients has not been sufficiently studied. There are no special precautions for the elderly, but individual conditions should be considered. This medication may affect certain clinical test results, so inform healthcare professionals of its intake during examinations. No specific symptoms have been reported for overdose, but general emergency care should be taken.

• Agranulocytosis
• neutropenia
• leukopenia
• skin rash
• allergic dermatitis
• pruritus
• urticaria
• facial edema
• anaphylactic reaction
• headache

This medication should be stored in a tightly closed container to prevent exposure to air or moisture. It is important to maintain a storage temperature between 1 and 30 degrees Celsius for effective preservation of the drug's efficacy.

Appearance

White oval tablets

Package unit

30 tablets/bottle, 90 tablets/bottle, 300 tablets/bottle